Filing Flows › Abbott Laboratories (ABT) › Operating margin
Abbott Laboratories (ABT) operating margin by quarter
Abbott Laboratories' operating margin was 10.4% in Q3 2026 (third quarter 2026), -3.0 pts from Q2 2026. Over the last 7 quarters it ranged from 10.4% (Q3 2026) to 19.6% (Q4 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 10.4% | -3.0 pts | -7.7 pts |
| Q2 2026 | 13.4% | +1.4 pts | -5.0 pts |
| Q1 2026 | 12.0% | -7.6 pts | -4.3 pts |
| Q4 2025 | 19.6% | +1.6 pts | — |
| Q3 2025 | 18.1% | -0.3 pts | — |
| Q2 2025 | 18.4% | +2.1 pts | — |
| Q1 2025 | 16.3% | — | — |
Q3 2026 at a glance
Abbott Laboratories, Q3 2026: revenue $13.0B (+14% year over year), operating margin 10.4%, net earnings $920M, operating cash flow $1.7B. The chart follows the revenue to costs, profit and cash.
Questions
What is Abbott Laboratories' operating margin?
Abbott Laboratories' operating margin was 10.4% in Q3 2026 (third quarter 2026), -3.0 pts from Q2 2026.
How has Abbott Laboratories' operating margin changed?
Over the last 7 quarters it ranged from 10.4% (Q3 2026) to 19.6% (Q4 2025).